Securities litigation study video series

Join PwC Partner Patricia Etzold as she hosts our Securities Litigation Video Series to gather insights from those who have expertise in areas including cybercrime, merger and acquisitions, and pharma and life science as they discuss today’s business environment and its implications for securities litigation.

Pharma and life science: How healthy is litigation risk resistance?

Pharma and life science: How healthy is litigation risk resistance?

Where are Pharmaceutical and life science companies significantly prone to litigation today? PwC Partner Patricia Etzold is joined by Christopher Albani, Principal, and Anup Kharode, director, PwC Pharmaceutical and Life Sciences for insight into what companies should know about risk-based innovation, product safety issues, and corruption in today's fast-paced, rapidly evolving health industry in a globally connected world.

Mitigating risks while doing due diligence

Mitigating risks while doing due diligence

As companies look to grow through deals, it's crucial that business leaders know where the specter of dispute tends to reside in the M&A process. PwC Partner Patricia Etzold asks the questions they need answers to in this informative interview with Transaction Services Partner Brian Vickrey and Kevin Kreb, PwC Forensic Services Partner, who discuss key risk areas, due diligence, and the importance of accounting methods and the legal language within purchase agreements.

Contact us

Kate Glenn
Forensic Services Marketing Director
Email

Follow us